Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
26.61B | 26.57B | 27.92B | 29.66B | 31.33B | 26.73B | Gross Profit |
6.94B | 6.85B | 6.62B | 7.01B | 6.52B | 6.04B | EBIT |
2.66B | 2.53B | 2.50B | 2.85B | 2.55B | 2.19B | EBITDA |
3.08B | 3.17B | 3.09B | 3.09B | 2.80B | 2.44B | Net Income Common Stockholders |
2.29B | 2.08B | 2.00B | 2.11B | 2.01B | 1.54B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.08B | 5.73B | 4.65B | 5.53B | 4.45B | 4.68B | Total Assets |
31.36B | 33.26B | 32.57B | 31.92B | 31.39B | 31.41B | Total Debt |
4.07B | 4.01B | 4.21B | 5.00B | 5.03B | 5.66B | Net Debt |
-15.00M | -1.72B | -434.00M | -528.00M | 589.00M | 979.00M | Total Liabilities |
10.04B | 11.39B | 11.12B | 11.82B | 12.23B | 13.74B | Stockholders Equity |
21.32B | 21.86B | 21.45B | 20.10B | 19.16B | 17.67B |
Cash Flow | Free Cash Flow | ||||
0.00 | 2.80B | 660.00M | 2.50B | 821.00M | 694.00M | Operating Cash Flow |
0.00 | 2.84B | 717.00M | 2.54B | 886.00M | 887.00M | Investing Cash Flow |
0.00 | 140.00M | 25.00M | -206.00M | -5.00M | -415.00M | Financing Cash Flow |
0.00 | -1.90B | -1.63B | -1.25B | -1.11B | -73.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | €80.60B | 4.35 | 14.23% | 0.90% | 6.88% | 19.10% | |
76 Outperform | ¥14.71B | 7.67 | 5.22% | -4.83% | 7.03% | ||
74 Outperform | ¥53.99B | 11.24 | 3.58% | 12.64% | 200.30% | ||
65 Neutral | ¥55.01B | 7.76 | 2.67% | -6.16% | -26.82% | ||
65 Neutral | ¥91.60B | 24.58 | 6.35% | 1.54% | 13.48% | -24.74% | |
51 Neutral | $2.01B | -1.26 | -21.11% | 4.38% | 2.92% | -30.46% | |
48 Neutral | ¥33.97B | ― | 15.85% | -25.73% | 84.97% |